Search in:

Advanced search

ClinicoEconomics and Outcomes Research Volume 7, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs

Enrica Menditto1 CIRFF, Center of Pharmacoeconomics, Federico II University of Naples, Naples, Italy

Valentina Orlando1 CIRFF, Center of Pharmacoeconomics, Federico II University of Naples, Naples, ItalyCorrespondence[email protected]

Silvia Coretti2 Postgraduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, School of Economics, Rome, Italy

Daria Putignano1 CIRFF, Center of Pharmacoeconomics, Federico II University of Naples, Naples, Italy

Denise Fiorentino1 CIRFF, Center of Pharmacoeconomics, Federico II University of Naples, Naples, Italy

Matteo Ruggeri2 Postgraduate School of Health Economics and Management (ALTEMS), Università Cattolica del Sacro Cuore, School of Economics, Rome, Italy

Pages 575-581 | Published online: 11 Nov 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

DranoveDWhiteWDAgency and the organization of health care deliveryInquiry1987244054152961701
PubMed Web of Science ®Google Scholar
PaulyMVMedicare drug coverage and moral hazardHealth Aff (Millwood)200423111312215002634
PubMed Web of Science ®Google Scholar
CoulsonNEStuartBCInsurance choice and the demand for prescription drugsSouthern Econ J199511461157
Web of Science ®Google Scholar
LundinDMoral hazard in physician prescription behaviorJ Health Econ200019563966211184797
PubMed Web of Science ®Google Scholar
EisenbergJMWilliamsSVCost containment and changing physicians’ practice behavior. Can the fox learn to guard the chicken coop?JAMA198124619219522017197307
PubMed Web of Science ®Google Scholar
BlackstoneEAJosephPFThe economics of biosimilarsAm Health Drug Benefits20136846947824991376
PubMedGoogle Scholar
ChauhanDTowseAMestre-FerrandizJThe market for biosimilars: evolution and policy optionsOHE Briefing, No. 45102008Social Science Research Network Available from: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2641004Accessed May 13, 2015
Google Scholar
RettigRAMedical innovation duels cost containmentHealth Aff (Millwood)19941337277927162
PubMed Web of Science ®Google Scholar
GreeneHLGoldbergRJBeattieHRussoAREllisonRCDalenJEPhysician attitudes toward cost containment: the missing piece of the puzzleArch Intern Med19891499196619682774777
PubMedGoogle Scholar
Axt-AdamPvan der WoudenJCvan der DoesEInfluencing behavior of physicians ordering laboratory tests: a literature studyMed Care1993317847948366680
PubMed Web of Science ®Google Scholar
Committee for Medicinal Products for Human UseGuideline on Similar Biological Medicinal ProductsLondonEuropean Medicines Agency2014 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/10/WC500176768.pdfAccessed February 19, 2015
Google Scholar
SchückSTexiersNBiosimilars: the French policyInt J Risk Saf Med2009214145
Google Scholar
MellstedtHNiederwieserDLudwigHThe challenge of biosimilarsAnn Oncol200819341141917872902
PubMed Web of Science ®Google Scholar
NiederwieserDSchmitzSBiosimilar agents in oncology/haematology: from approval to practiceEur J Haematol201186427728821175852
PubMed Web of Science ®Google Scholar
Agenzia Italiana del Farmaco. AIFAAIFA position paper. I farmaci biosimilari [Biosimilars] Available at: http://www.agenziafarmaco.gov.it/sites/default/files/AIFA_POSITION_PAPER_FARMACI_BIOSIMILARI.pdfAccessed May 13, 2015 Italian
Google Scholar
IngrasciottaYGiorgianniFBolcatoJHow much are biosimilars used in clinical practice? A retrospective Italian population-based study of erythropoiesis-stimulating agents in the years 2009–2013BioDrugs201529427528426169209
PubMed Web of Science ®Google Scholar
IMS Health [homepage on the internet] Available from: http://www.imshealth.com/portal/site/imshealthAccessed May 13, 2015
Google Scholar
Decreto n. 15 del 30 novembre 2009. [Decree number 15, November 30, 2009] Available from: http://www.aslna3sud.it/regione/DECRETO_15_DELIBERAZIONI_DEL_COMMISSARIO_AD_ACTAAccessed May 13, 2015 Italian
Google Scholar
Decreto commisariale n. 44 del 14/07/2010. [Decree number 44, July 14, 2010] Available from: http://www.aslcaserta.it/portale/Portals/0/doc_pub/2012/ATTIREGIONE/dca_44_Misure%20di%20controllo%20spesa%20farmaceutica.pdfAccessed May 13, 2015 Italian
Google Scholar
Decreto n. 34 del 20.03.2012. [Decree number 34, March 20, 2012] Available from: http://www.aslcaserta.it/portale/Portals/0/doc_pub/2012/ATTIREGIONE/34_Farmaci%20biosimilari.pdfAccessed May 13, 2015 Italian
Google Scholar
Decreto n. 27 del 15.03.2013. [Decree number 27, March 15, 2012] Available from: http://www.arsan.campania.it/documents/10157/59773/DCA_27_13.pdfAccessed May 13, 2015 Italian
Google Scholar
HausteinRde MillasCHöerAHäusslerBSaving money in the European healthcare systems with biosimilarsGenerics Biosimilars Initiat J201213–4120126
Google Scholar
Farfan-PortetMIGerkensSLepage-NefkensIVinckIHulstaertFAre biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?Eur J Health Econ201415322322824271016
PubMed Web of Science ®Google Scholar
SchwartzRKSoumeraiSBAvornJPhysician motivations for nonscientific drug prescribingSoc Sci Med19892865775822648605
PubMed Web of Science ®Google Scholar
HogerzeilHVPromoting rational prescribing: an international perspectiveBr J Clin Pharmacol1995391167756093
PubMed Web of Science ®Google Scholar
WeiseMBielskyMCDe SmetKBiosimilars: what clinicians should knowBlood2012120265111511723093622
PubMed Web of Science ®Google Scholar
GodmanBWettermarkBvan WoerkomMMultiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implicationsFront Pharmacol201417510624987370
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Doctors commitment and long-term effectiveness for cost containment policies: lesson learned from biosimilar drugs

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date